Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Drug management in chronic rhinosinusitis: identification of the needs

Authors Jean-Baptiste HPJ Watelet, Philippe H Eloy, Paul B van Cauwenberge

Published 15 March 2007 Volume 2007:3(1) Pages 47—57

Jean-Baptiste HPJ Watelet1, Philippe H Eloy2, Paul B van Cauwenberge1

1Department of Otorhinolaryngology, University of Ghent, Ghent, Belgium; 2Department of Otorhinolaryngology, CHU Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium

Abstract: Chronic rhinosinusitis (CRS) is a group of multifactorial diseases characterized by inflammation of the mucosa of the nose and paranasal sinuses with a history of at least 12 weeks of persistent symptoms despite maximal medical therapy. The precise role played by infection and immunoglobin E (IgE)-mediated hypersensitivity remains unclear. Diagnosis of CRS is based upon medical history, nasal endoscopy and computed tomography scan of the sinuses. The CRS with polyps visible in the middle meatus must be distinguished from the CRS without polyps. Based on the current knowledge about the pathogenesis of CRS, it is admitted that an optimal medical treatment must consider all favorizing factors and control efficaciously the inflammation process. In case of failure of medical treatment, endoscopic sinus surgery should be proposed. However, some well-validated data and scientific evidences are missing, even for the most frequently used medications. After a review of the actual definitions and classifications, a short description of the current knowledge about pathogenesis of CRS is provided in order to justify the actual therapeutic rationales and identify the needs for an effective treatment of CRS.

Keywords: rhinosinusitis, pathogenesis, diagnosis, management, guidelines

Download Article [PDF] 

Readers of this article also read:

Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles

Melguizo C, Cabeza L, Prados J, Ortiz R, Caba O, Rama AR, Delgado ÁV, Arias JL

Drug Design, Development and Therapy 2015, 9:6433-6444

Published Date: 14 December 2015

An unusual case of prostate tuberculosis: a case report

Abdulsalam AJ, Abdulsalam MA

International Medical Case Reports Journal 2015, 8:99-102

Published Date: 2 May 2015

Experimental study of tissue-engineered cartilage allograft with RNAi chondrocytes in vivo

Wang ZH, Li XL, He XJ, Zhang XH, Yang ZQ, Xu M, Wu BJ, Tu JB, Luo HN, Yan J

Therapeutics and Clinical Risk Management 2014, 10:335-340

Published Date: 8 May 2014

A rehabilitation program for lung cancer patients during postthoracotomy chemotherapy

Hoffman AJ, Brintnall RA, von Eye A, Jones LW, Alderink G, Patzelt LH, Brown JK

OncoTargets and Therapy 2014, 7:415-423

Published Date: 10 March 2014

Cortical mapping with navigated transcranial magnetic stimulation in low-grade glioma surgery

Paiva WS, Fonoff ET, Marcolin MA, Cabrera HN, Teixeira MJ

Neuropsychiatric Disease and Treatment 2012, 8:197-201

Published Date: 3 May 2012

Guaifenesin and increased sperm motility: a preliminary case report

Gary Means, Cristóbal S Berry-Cabán, Kurt Hammermeuller

International Journal of General Medicine 2011, 4:13-14

Published Date: 20 December 2010

Potential diagnostic applications of biosensors: current and future directions

Shiping Song, Hui Xu, Chunhai Fan

International Journal of Nanomedicine 2006, 1:433-440

Published Date: 15 January 2007